Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Article
in En
| MEDLINE
| ID: mdl-36626583
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, Large B-Cell, Diffuse
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Blood
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos